Inhibition of cell-mediated lysis by xenoantibodies reactive with effector T lymphocytes.

The aim of the present study was to determine whether rabbit antisera against various murine tissue antigens contain antibodies that affect the activity of cytotoxic T lymphocytes in the absence of complement. Following heat inactivation, the xenoantisera were absorbed with mouse liver and kidney and tested for their capacity to inhibit cell-mediated lysis (CML). In the presence of complement (C), rabbit anti-brain antiserum (RABr), rabbit anti-thymus antiserum (RAT) and rabbit anti-boiled thymus antiserum (RABT) lysed effector T cells, and CML was abolished. In the absence of C, RAT maintained its strong inhibitory activity on CML, RABr had no inhibitory effect, whereas only some batches of RABT were effective. Monovalent Fab fragments of RAT inhibited CML as effectively as intact antibody molecules. The activity of RAT could be removed by absorption with T and B lymphocytes of various sources. Inhibitory antibodies could be removed by absorption with C3 H B lymphoma cells and upon elution from antibody-coated cells proved again highly effective in inhibiting CML. These results show that RAT contains antibodies which react with determinants shared by T and B lymphocytes and which block the activity of cytotoxic T cells.
AuthorsR Rabinowitz, R Laskov, M Schlesinger
JournalEuropean journal of immunology (Eur J Immunol) Vol. 10 Issue 3 Pg. 219-23 (Mar 1980) ISSN: 0014-2980 [Print] GERMANY, WEST
PMID6155273 (Publication Type: Journal Article)
Chemical References
  • Antibodies, Heterophile
  • Epitopes
  • Complement System Proteins
  • Animals
  • Antibodies, Heterophile (immunology)
  • B-Lymphocytes (immunology)
  • Complement System Proteins (immunology)
  • Cytotoxicity, Immunologic
  • Epitopes
  • Mice
  • Mice, Inbred BALB C
  • Rabbits
  • T-Lymphocytes (classification, immunology)
  • Thymus Gland (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: